Pharmacological treatment of Parkinson disease: a review.

@article{Connolly2014PharmacologicalTO,
  title={Pharmacological treatment of Parkinson disease: a review.},
  author={B. Connolly and A. Lang},
  journal={JAMA},
  year={2014},
  volume={311 16},
  pages={
          1670-83
        }
}
  • B. Connolly, A. Lang
  • Published 2014
  • Medicine
  • JAMA
  • IMPORTANCE Parkinson disease is the second most common neurodegenerative disease worldwide. [...] Key MethodEVIDENCE REVIEW References were identified using searches of PubMed between January 1985 and February 2014 for English-language human studies and the full database of the Cochrane Library. The classification of studies by quality (classes I-IV) was assessed using the levels of evidence guidelines from the American Academy of Neurology and the highest-quality data for each topic. Expand Abstract
    739 Citations

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    The purpose of this study is to select the safest and most effective number of repeat doses of allogeneic bone marrow-derived mesenchymal stem cell (MSC) infusions to slow the… Expand
    ConditionsParkinson's Disease
    InterventionDrug
    OBSERVATIONAL CLINICAL TRIAL
    The purpose of this study is to evaluate how safinamide, rasagiline and other SoC drugs are associated with the quality of life of PD patients by means of the Parkinson's Disease… Expand
    ConditionsParkinson's Disease
    INTERVENTIONAL CLINICAL TRIAL
    The study will look into the changes of Deep Brain Stimulation (DBS) measured impedances in patients of Parkinson disease (PD) as a function of their functional state (lying, sitting… Expand
    ConditionsParkinson Disease
    InterventionOther
    Pharmacological Treatment in Parkinson’s Disease
    • 1
    • Highly Influenced
    • PDF
    Treating the Motor Symptoms of Parkinson Disease
    • 12
    Cholinesterase inhibitors for Parkinson's disease: a systematic review and meta-analysis
    • 59
    • PDF
    Initial management of Parkinson’s disease
    • 29
    • PDF
    Treatment of Older Parkinson's Disease.
    • 6

    References

    SHOWING 1-10 OF 163 REFERENCES
    Impact of standard of care for psychosis in Parkinson disease
    • 21
    Management of hallucinations and psychosis in Parkinson's disease.
    • M. Eng, T. Welty
    • Medicine
    • The American journal of geriatric pharmacotherapy
    • 2010
    • 40
    • PDF
    The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
    • 371
    • PDF